Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Mianserin, a medication with the chemical name 2-amino-N-(4,5-dihydro-1H-imidazol-2-yl)-4-methoxybenzamide, is an atypical tricyclic compound that functions as a serotonin receptor antagonist. It is primarily used for its antidepressant properties and is known for its unique mechanism of action, which involves blocking the reuptake of serotonin and norepinephrine in the brain. Mianserin is characterized by its effectiveness in treating depressive symptoms without causing significant side effects, such as weight gain or sexual dysfunction, which are common with other antidepressants.

24219-97-4 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • Dibenzo[c,f]pyrazino[1,2-a]azepine,1,2,3,4,10,14b-hexahydro-2-methyl-

    Cas No: 24219-97-4

  • USD $ 1.9-2.9 / Gram

  • 100 Gram

  • 1000 Metric Ton/Month

  • Chemlyte Solutions
  • Contact Supplier
  • 24219-97-4 Structure
  • Basic information

    1. Product Name: MIANSERIN
    2. Synonyms: Dibenzoc,fpyrazino1,2-aazepine, 1,2,3,4,10,14b-hexahydro-2-methyl-;MIANSERIN,1.0MG/MLINMETHANOL;Dibenzo[c,f]pyrazino[1,2-a]azepine, 1,2,3,4,10,14b-hexahydro-2-methyl- (8CI, 9CI);MIANSERIN (1.0MG/ML METHANOL);(14bS)-1,2,3,4,10,14b-Hexahydro-2-methyldibenzo[c,f]pyrazino[1,2-a]azepine;(14bS)-2-Methyl-1,2,3,4,10,14bα-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine;(S)-Mianserine;[14bS,(+)]-1,2,3,4,10,14bα-Hexahydro-2-methyldibenzo[c,f]pyrazino[1,2-a]azepine
    3. CAS NO:24219-97-4
    4. Molecular Formula: C18H20N2
    5. Molecular Weight: 264.36
    6. EINECS: 246-088-6
    7. Product Categories: Intermediates & Fine Chemicals;Pharmaceuticals
    8. Mol File: 24219-97-4.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 397.6°C (rough estimate)
    3. Flash Point: 186.1°C
    4. Appearance: /
    5. Density: 1.0092 (rough estimate)
    6. Refractive Index: 1.5200 (estimate)
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. PKA: pKa 7.5(H2O,t =20.0) (Uncertain)
    10. CAS DataBase Reference: MIANSERIN(CAS DataBase Reference)
    11. NIST Chemistry Reference: MIANSERIN(24219-97-4)
    12. EPA Substance Registry System: MIANSERIN(24219-97-4)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. RIDADR: 3249
    5. WGK Germany:
    6. RTECS:
    7. HazardClass: 6.1(b)
    8. PackingGroup: III
    9. Hazardous Substances Data: 24219-97-4(Hazardous Substances Data)

24219-97-4 Usage

Uses

Used in Pharmaceutical Industry:
Mianserin is used as an antidepressant for treating major depressive disorder and other mood disorders. It works by blocking the reuptake of serotonin and norepinephrine, leading to an increase in the levels of these neurotransmitters in the brain, which helps alleviate depressive symptoms.
Used in Research and Development:
Mianserin is also utilized in the research and development of new medications and therapies for various psychiatric and neurological conditions. Its unique mechanism of action and relatively low side effect profile make it a valuable tool for studying the role of serotonin and norepinephrine in mood regulation and other brain functions.
Brand Names:
Mianserin is available under various brand names, including Athimil, Athymil, Bolvidon, Lantanon, Lerivon, Miansan, Norval, Org GB 94, Tolvin, and Tolvon. These brand names may vary by country and manufacturer, but they all refer to the same active ingredient, Mianserin, which is used for its antidepressant properties.

Therapeutic Function

Serotonin antagonist, Antihistaminic

World Health Organization (WHO)

Mianserin, a serotonin antagonist with antidepressant and antihistaminic activity, was introduced in 1975 for the treatment of depressive illness. Its use has since been associated with cases of severe blood dyscrasias, particularly in elderly patients, including agranulocytosis, leucopenia and granulocytopenia. Several drug regulatory authorities have reacted by stipulating that blood counts should be monitored regularly during the first few months of treatment and that administration should be discontinued immediately should any signs possibly indicative of dyscrasia develop.

Check Digit Verification of cas no

The CAS Registry Mumber 24219-97-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,4,2,1 and 9 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 24219-97:
(7*2)+(6*4)+(5*2)+(4*1)+(3*9)+(2*9)+(1*7)=104
104 % 10 = 4
So 24219-97-4 is a valid CAS Registry Number.
InChI:InChI=1S/C18H20N2/c1-19-10-11-20-17-9-5-3-7-15(17)12-14-6-2-4-8-16(14)18(20)13-19/h2-9,18H,10-13H2,1H3

24219-97-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name mianserin

1.2 Other means of identification

Product number -
Other names [3H]-(+/-)-Mianserin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:24219-97-4 SDS

24219-97-4Relevant articles and documents

A Modular Approach to Dibenzo-fused ?-Lactams: Palladium-Catalyzed Bridging-C?H Activation

Huang, Xueliang,Ma, Liyao,Xia, Jiajin,Xin, Luoting,Yu, Yinghua,Zhu, Lei

, p. 18261 - 18266 (2020/08/21)

Tricyclic ring systems possessing a dibenzo structure joined to a seven-membered heterocyclic ring frequently show important biological activities. However, a modular approach to these molecules based on efficient intermolecular reaction of readily available chemicals is lacking. Herein, an unprecedented palladium-catalyzed formal [4+3] annulation for modular construction of these tricyclic systems is described. This reaction features easily accessible reactants (o-haloarylaldehydes and N-tosylhydrazones), broad substrate scope, and excellent functional group compatibility. The synthetic potential is demonstrated by the easy scale-up reactions, late-stage modification of complex molecules, and collective synthesis of bioactive molecules and approved drugs.

The enantioselective synthesis of (S)-(+)-mianserin and (S)-(+)-epinastine

Roszkowski, Piotr,Maurin,Czarnocki, Zbigniew

, p. 1509 - 1513 (2016/04/09)

A simple enantioselective synthetic procedure for the preparation of mianserin and epinastine in optically pure form is described. The key step in the synthetic pathway is the asymmetric reduction of the cyclic imine using asymmetric transfer hydrogenation conditions.

PROCESS FOR PRODUCTION OF MIRTAZAPINE

-

Page/Page column 5-6, (2009/12/28)

The invention provides a process for production of mirtazapine as a convenient process for obtaining mirtazapine from a reaction mixture obtained by cyclization of 2-(4-methyl-2-phenylpiperazin-1-yl)pyridine-3-methanol with concentrated sulfuric acid, at high purity and in a form suitable for safe use as a drug. The production process for mirtazapine is characterized in that a reaction mixture obtained by cyclization of 2-(4-methyl-2-phenylpiperazin-1-yl)pyridine-3-methanol with concentrated sulfuric acid is diluted with water, the dilution is alkalinized in the presence of propanol, the mirtazapine is extracted with propanol and the mirtazapine is crystallized from the extract.

EXPERIMENTAL ANTIULCER AGENTS: N-SUBSTITUTED 2-(4-METHYL-1-PIPERAZINYL)ACETAMIDES AS PIRENZEPINE MODELS AND SOME RELATED COMPOUNDS

Hulinska, Hana,Polivka, Zdenek,Jilek, Jiri,Sindelar, Karel,Holubek, Jiri,et al.

, p. 1820 - 1844 (2007/10/02)

Reactions of N-cyclohexyl-2-chloroacetamide, N-phenyl-2-chloroacetamide, N-(4-dimethylaminophenyl)-2-chloroacetamide, N-(2-nitrophenyl)-N-phenyl-2-chloroacetamide, its 3-nitrophenyl and 4-nitrophenyl analogues, N-(2-benzylphenyl)-2-chloroacetamide, 5-(chloroacetyl)dibenzazepine, and its 10,11-dihydro derivative with piperazine, 1-methylpiperazine, 2-(1-piperazinyl)ethanol, and 3-(1-piperazinyl)propanol resulted in compounds II, III, V -XV, XVIII, XXI, and XXIII, simple analogues of the antiulcer agent pirenzepine (I).Contributions to the syntheses and characterization of mianserin (XIX), bisnor analogue of imipramine (XXV), and pirenzepine (I) are presented.Two 2-aryl-2-(2-pyridyl)thioacetamides XXXVIII and XL were synthesized via nitriles XXXIX and XLI.Compounds XI (VUFB-17 104) and XXI (VUFB-17 113) were found to be rather effective as anti-ulcer agents and anticholinergics.

Tris[tetrahydroisoquinoline] compounds

-

, (2008/06/13)

Novel alkylenetris- and alkylenetetrakis-[1,2,3,4-tetrahydroisoquinoline] and -[3,4-dihydroisoquinoline] compounds, the pharmaceutically acceptable acid addition salts thereof and compositions containing such substances have been found useful for inhibiting the formation of blood clots in mammals and/or dissolving blood clots in mammals after they have been formed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 24219-97-4